Form D · Biotechnology
SAVICELL Corp
Andover, MA · CIK 0001498380
Offering snapshot reported Aug 18, 2023 · SEC filing
- Reported sold
- $224K Offering amount: $224K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 11, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 18, 2023 | Initial | $224,000 | No comparison | 2 | SEC filing |
| Nov 15, 2022 | Initial | $174,999 | No comparison | 3 | SEC filing |
| Oct 14, 2021 | Initial | $113,000 | No comparison | 2 | SEC filing |
| Dec 28, 2020 | Initial | $17,850 | No comparison | 1 | SEC filing |
| Dec 4, 2020 | Initial | $300,000 | No comparison | 1 | SEC filing |
| Oct 29, 2019 | Initial | $12,000 | No comparison | 1 | SEC filing |
| Apr 15, 2019 | Initial | $50,000 | No comparison | 1 | SEC filing |
| Mar 8, 2019 | Initial | $50,000 | No comparison | 1 | SEC filing |
| Jan 17, 2018 | Initial | $200,000 | No comparison | 1 | SEC filing |
| May 5, 2017 | Initial | $250,000 | No comparison | 1 | SEC filing |
| Dec 10, 2012 | Initial | $21,000 | No comparison | 2 | SEC filing |
| Nov 26, 2012 | Initial | $68,733 | No comparison | 2 | SEC filing |
| Aug 2, 2012 | Amendment | $9,000 | $0vs Jul 31, 2012 | 5 | SEC filing |
| Jul 31, 2012 | Initial | $9,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-490081
Source: Form D, filed Aug 18, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Irit Arbel | Director |
| Benjamin Chernaik | Director |
| Benjamin Cherniak | Director |
| Giora Davidovits | Director, Executive |
| David Eyal Davidovits | Director, Executive |
| Eyal Davidovits | Director, Executive |
| David Eyal Davidovits | Director |
| Robbie Manis | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
10 Stevens Street, Po Box 1080
Andover, MA, 01810-3572
Andover, MA, 01810-3572